Grants We Funded
Grant applicants for the 2023 cycle requested a total of nearly $4 million dollars. The PSF Study Section Subcommittees of Basic & Translational Research and Clinical Research evaluated nearly 140 grant applications on the following topics:
The PSF awarded research grants totaling over $1 million dollars to support nearly 30 plastic surgery research proposals.
ASPS/PSF leadership is committed to continuing to provide high levels of investigator-initiated research support to ensure that plastic surgeons have the needed research resources to be pioneers and innovators in advancing the practice of medicine.
Research Abstracts
Search The PSF database to have easy access to full-text grant abstracts from past PSF-funded research projects 2003 to present. All abstracts are the work of the Principal Investigators and were retrieved from their PSF grant applications. Several different filters may be applied to locate abstracts specific to a particular focus area or PSF funding mechanism.
Is Hyperbaric Oxygen Therapy Safe in Cancer Patients?
C. Suzanne Cutter MD
2004
Memorial Sloan-Kettering Cancer Center
Basic Research Grant
General Reconstructive
Wound healing complications after oncologic surgery can have devastating consequences. These difficulties may delay adjuvant therapy and impair aesthetics and functional reconstruction. Numerous studies have shown the efficacy of hyperbaric oxygen therapy (HBOT) in the treatment of difficult wounds. For example, HBOT is effective in the treatment of osteoradionecrosis, ischemic flaps, gas gangrene, chronic wounds in diabetics, crush injuries, refractory chronic osteomyelitis, burns, and soft tissue radiation necrosis. However, fear of cancer cell activation or biologic alteration has led to a reluctance to use this therapeutic modality in cancer patients. For these patients, oncologic resections resulting from breast and head and neck malignancies represent the most common defects requiring reconstruction. Therefore, the purpose of these studies is to rigorously assess the effects of HBOT on breast and head and neck cancer cells as well as to determine the safety of this modality in the treatment of difficult wounds in this setting.